Weiss Ratings Reaffirms Sell (E+) Rating for 10x Genomics (NASDAQ:TXG)
10x Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating reaffirmed by stock analysts at Weiss Ratings in a research report issued to clients and investors on Saturday,Weiss Ratings reports. Several other analysts have also recently commented on the stock. JPMorgan Chase & Co. reduced their price objective on shares of 10x […]
10x Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating reaffirmed by stock analysts at Weiss Ratings in a research report issued to clients and investors on Saturday,Weiss Ratings reports. Several other analysts have also recently commented on the stock. JPMorgan Chase & Co. reduced their price objective on shares of 10x […]
